Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


Exercise-induced lung cancer regression: mechanistic findings from a mouse model.

Higgins KA, Park D, Lee GY, Curran WJ, Deng X.

Cancer. 2014 Nov 1;120(21):3302-3310. doi: 10.1002/cncr.28878. Epub 2014 Jul 2.


The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.

Shao C, Zhao L, Wang K, Xu W, Zhang J, Yang B.

World J Surg Oncol. 2012 Aug 6;10:160. doi: 10.1186/1477-7819-10-160.


p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.

Katiyar SK, Meeran SM, Katiyar N, Akhtar S.

Mol Carcinog. 2009 Jan;48(1):24-37. doi: 10.1002/mc.20453.


Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer.

Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST, Freedland SJ, Potter MQ, Moon EJ, Schroeder T, Herndon JE 2nd, Dewhirst MW.

J Appl Physiol (1985). 2010 Feb;108(2):343-8. doi: 10.1152/japplphysiol.00424.2009. Epub 2009 Dec 3. Erratum in: J Appl Physiol. 2010 Apr;108(4):1021.


β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.

Li J, JunYu, Liu A, Wang Y.

Lung Cancer. 2014 Nov;86(2):144-50. doi: 10.1016/j.lungcan.2014.08.015. Epub 2014 Aug 29. Retraction in: Lung Cancer. 2016 Jun;96:120.


Glucosidase II exhibits similarity to the p53 tumor suppressor in regards to structure and behavior in response to stress signals: a potential novel cancer biomarker.

Suradej B, Pata S, Kasinrerk W, Cressey R.

Oncol Rep. 2013 Nov;30(5):2511-9. doi: 10.3892/or.2013.2721. Epub 2013 Sep 5.


Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.

Wang S, Liu JC, Kim D, Datti A, Zacksenhaus E.

Breast Cancer Res. 2016 Jan 19;18(1):9. doi: 10.1186/s13058-015-0668-y.


p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.

Mashima T, Oh-hara T, Sato S, Mochizuki M, Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y, Kato Y, Tomoda H, Yamori T, Tsuruo T.

J Natl Cancer Inst. 2005 May 18;97(10):765-77.


Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.

Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, Xie WP, Hou YY.

BMC Cancer. 2013 Oct 7;13:461. doi: 10.1186/1471-2407-13-461.


Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.

Su Z, Wang K, Li R, Yin J, Hao Y, Lv X, Li J, Zhao L, Du Y, Li P, Zhang J.

World J Surg Oncol. 2016 Feb 29;14:57. doi: 10.1186/s12957-016-0815-7.


Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin.

Wang S, Li W, Xue Z, Lu Y, Narsinh K, Fan W, Li X, Bu Q, Wang F, Liang J, Wu K, Cao F.

Mol Carcinog. 2013 Nov;52(11):900-7. doi: 10.1002/mc.21930. Epub 2012 Jun 5.


PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF.

Chen K, Luo Z, Li Z, Liu Y, Zhao Q.

Cancer Biol Ther. 2011 Dec 15;12(12):1114-9. doi: 10.4161/cbt.12.12.18435. Epub 2011 Dec 15.


Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549.

Ye B, Xie Y, Qin ZH, Wu JC, Han R, He JK.

Acta Pharmacol Sin. 2011 Nov;32(11):1397-401. doi: 10.1038/aps.2011.116. Epub 2011 Sep 26.


VSV-MP gene therapy strategy inhibits tumor growth in nude mice model of human lung adenocarcinoma.

Jing XM, Wen YJ, Shi W, Tang QQ, Li J, Chen XC.

Cancer Gene Ther. 2012 Feb;19(2):101-9. doi: 10.1038/cgt.2011.71. Epub 2011 Nov 4.


miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Kasinski AL, Slack FJ.

Cancer Res. 2012 Nov 1;72(21):5576-87. doi: 10.1158/0008-5472.CAN-12-2001. Epub 2012 Sep 10.


Daily exercise prevents diastolic dysfunction and oxidative stress in a female mouse model of western diet induced obesity by maintaining cardiac heme oxygenase-1 levels.

Bostick B, Aroor AR, Habibi J, Durante W, Ma L, DeMarco VG, Garro M, Hayden MR, Booth FW, Sowers JR.

Metabolism. 2017 Jan;66:14-22. doi: 10.1016/j.metabol.2016.09.005. Epub 2016 Sep 22.


p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.

Powell E, Shao J, Yuan Y, Chen HC, Cai S, Echeverria GV, Mistry N, Decker KF, Schlosberg C, Do KA, Edwards JR, Liang H, Piwnica-Worms D, Piwnica-Worms H.

Breast Cancer Res. 2016 Jan 27;18(1):13. doi: 10.1186/s13058-016-0673-9.


Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer.

Perera SA, Maser RS, Xia H, McNamara K, Protopopov A, Chen L, Hezel AF, Kim CF, Bronson RT, Castrillon DH, Chin L, Bardeesy N, Depinho RA, Wong KK.

Carcinogenesis. 2008 Apr;29(4):747-53. doi: 10.1093/carcin/bgn050. Epub 2008 Feb 17.


Supplemental Content

Support Center